Aptose Biosciences Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Product Pipeline
    • Overview
    • CG-806 for B-cell Tumors
    • CG-806 for Myeloid Tumors
    • APTO-253
    • Posters & Presentations
  • Clinical Trials
    • Overview
    • CG-806 for CLL & NHL
    • CG-806 for AML
    • APTO-253 for AML & MDS
  • News
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Governance
  • Careers
  • Contact

Press Releases

News

News

  • Press Releases
  • Presentations
  • Events

OHSU and Aptose Present New CG-806 Preclinical Data at ASH 60th Annual Meeting

Dec 03, 2018 7:10am EST

Aptose Presents New Preclinical Data on CG-806 PAN-FLT3/PAN-BTK Inhibitor at ASH 60th Annual Meeting

Dec 03, 2018 7:05am EST

Aptose Biosciences Doses First Patient in Re-Initiation of Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Malignancies

Nov 26, 2018 7:05am EST

Aptose to Participate in Upcoming Investor Conferences, Host Key Opinion Leader Event, and Present Data at the Upcoming ASH Meeting

Nov 20, 2018 7:05am EST

Aptose Reports Results for the Third Quarter Ended September 30, 2018

Nov 06, 2018 4:05pm EST

Aptose to Present New CG-806 Data at the 2018 ASH Annual Meeting

Nov 01, 2018 9:26am EDT

Aptose to Release Third Quarter Ended September 30, 2018 Financial Results on November 6, 2018

Oct 23, 2018 7:05am EDT

Aptose Biosciences and CrystalGenomics Announce Issuance of European Patent for CG-806

Sep 27, 2018 7:05am EDT

Aptose to Present at Upcoming Investor Conferences in October 2018

Sep 25, 2018 7:05am EDT

Aptose to Present at Upcoming Investor Conferences in September 2018

Aug 29, 2018 7:05am EDT
RSS
  • Prev
    • 1...
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • ...20
    Next
    © 2021 Aptose Biosciences Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap